Morgens Waterfall Vintiadis & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.28M Hold
9,000
10.2% 3
2025
Q4
$9.67M Hold
9,000
7.08% 2
2025
Q3
$6.87M Hold
9,000
4.71% 9
2025
Q2
$7.02M Hold
9,000
5.15% 7
2025
Q1
$7.43M Hold
9,000
8.43% 4
2024
Q4
$6.95M Hold
9,000
5.31% 5
2024
Q3
$7.97M Hold
9,000
6.17% 5
2024
Q2
$8.15M Sell
9,000
-1,000
-10% -$800K 6.2% 4
2024
Q1
$7.78M Hold
10,000
5.38% 5
2023
Q4
$5.83M Sell
10,000
-100
-1% -$58.4K 4.33% 9
2023
Q3
$5.43M Sell
10,100
-700
-6% -$361K 4.39% 9
2023
Q2
$5.06M Buy
10,800
+1,800
+20% +$755K 3.6% 12
2023
Q1
$3.09M Sell
9,000
-2,000
-18% -$675K 2.54% 18
2022
Q4
$4.02M Sell
11,000
-900
-8% -$319K 3.49% 9
2022
Q3
$3.85M Hold
11,900
4.22% 8
2022
Q2
$3.86M Buy
+11,900
New +$3.57M 3.62% 13

Other funds holding LLY

Morgens Waterfall Vintiadis & Co's LLY Position: Q1 2026 in Review

Morgens Waterfall Vintiadis & Co held its Eli Lilly (LLY) position steady in Q1 2026 at 9,000 shares worth $8.28M. The position accounts for 10.2% of the portfolio, ranked #3.

Morgens Waterfall Vintiadis & Co first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $9.67M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Morgens Waterfall Vintiadis & Co held 9,000 shares of Eli Lilly worth $8.28M as of Q1 2026.
  • Morgens Waterfall Vintiadis & Co left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 10.2% of Morgens Waterfall Vintiadis & Co's portfolio in Q1 2026, its #3 holding.
  • Morgens Waterfall Vintiadis & Co first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
  • Morgens Waterfall Vintiadis & Co's Eli Lilly position peaked at $9.67M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q1 2026, filed 15 May 2026.